Heliyon · 2023 · 11 citations · 29 references
MedicineMolecular BiologyOncologyCancer GeneticsMolecular OncologyNeoplasiaCancer BiomarkersCancer Molecular DiagnosticsCancer StagingLung CancerMolecular Classification Of TumorsMolecular Tumor ProfilingCancer Genomics DatabasesDisease-free Survival AnalysisDisease-free Survival AssessmentLung Cancer PathologyLung Cancer StagingPrognostic Expression SignaturesPrognostic Marker AssessmentTnm Staging System
Non-small cell lung cancer (NSCLC), as the main type of lung cancer, has a long history of high incidence and mortality. Despite the continuous updates to the American Joint Committee on Cancer (AJCC) staging system, which adapt to evolving treatment modalities and diagnostic advancements, it is evident that patients at the same stage exhibit varying prognoses. The heterogeneity of tumors underscores the need for molecular diagnostics to assume a pivotal role in tumor staging and patient stratification. In our investigation, we meticulously analyzed the data of the Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) database, incorporating clinical patients and scrutinizing pathological specimens. Through this comprehensive approach, we established a correlation between the expression of the Thymosin beta 4 X-linked (TMSB4X) gene and poorer disease-free survival (DFS) and overall survival (OS) post-surgery. Compared to the TMSB4X positive expression group, patients in the negative expression group had a better prognosis, with longer DFS (median disease-free survival (median DFS): 16.2 months vs. 11.3 months, P = 0.032) and OS (median overall survival (mOS): 29.8 months vs. 18.5 months, P = 0.033). Furthermore, our findings suggest that TMSB4X may facilitate immune evasion in non-small cell lung cancer cells by influencing the activation of infiltrating dendritic cells (DCs) in tumor infiltration immune cells (TIICs) (R = 0.27, P = 4.8E+08). In summary, TMSB4X emerges as an unfavorable prognostic factor for NSCLC, potentially modulating the tumor immune microenvironment through its regulatory impact on dendritic cell function, thus facilitating tumor immune escape.
29
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman, Chih Long Liu, Michael R. Green et al. · Nature Methods · 2015 · 14.1K citations · Full text
Profiling Tumor Infiltrating Immune Cells with CIBERSORT
Binbin Chen, Michael S. Khodadoust, Chih Long Liu et al. · Methods in molecular biology · 2018 · 4.2K citations · Full text
Medicine, Immunology, Oncology +12